December 9, 2013—The federal government is yet again postponing final regulations for the calculation of a drug’s average manufacture price (AMP) under the Medicaid drug rebate program.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)